United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7354_d005db80-b81e-4587-8a6d-8004770e1720
- Product NDC
- 50090-7354
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- A-S Medication Solutions
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230310
- Source listing expiry
- 20261231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (50090-7354-0) · 50090-7354-0
- 45 CAPSULE in 1 BOTTLE (50090-7354-1) · 50090-7354-1
- 16 CAPSULE in 1 BOTTLE (50090-7354-2) · 50090-7354-2
- 40 CAPSULE in 1 BOTTLE (50090-7354-3) · 50090-7354-3
- 20 CAPSULE in 1 BOTTLE (50090-7354-4) · 50090-7354-4
- 3 CAPSULE in 1 BOTTLE (50090-7354-5) · 50090-7354-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →